Larvol Delta - Safety-of-AVMEL1-With-AntiPD1-Therapy-in-Metastatic-Melanoma

AV-MEL-1 - AiVita Biomedical

http://clinicaltrials.gov/ct2/show/NCT03743298

Apr 23, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next